Accepted Manuscript Central sympathetic nervous system reinforcement in obstructive sleep apnoea Magdalena Wszedybyl-Winklewska, Jacek Wolf, Arkadiusz Szarmach, Pawel J. Winklewski, Edyta Szurowska, Krzysztof Narkiewicz PII:
S1087-0792(17)30172-7
DOI:
10.1016/j.smrv.2017.08.006
Reference:
YSMRV 1059
To appear in:
Sleep Medicine Reviews
Received Date: 14 March 2016 Revised Date:
29 August 2017
Accepted Date: 31 August 2017
Please cite this article as: Wszedybyl-Winklewska M, Wolf J, Szarmach A, Winklewski PJ, Szurowska E, Narkiewicz K, Central sympathetic nervous system reinforcement in obstructive sleep apnoea, Sleep Medicine Reviews (2017), doi: 10.1016/j.smrv.2017.08.006. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
RI PT
ACCEPTED MANUSCRIPT
Central sympathetic nervous system reinforcement in obstructive
SC
sleep apnoea
1#
M AN U
Running title: Central SNS outflow and obstructive sleep apnoea
Magdalena Wszedybyl-Winklewska , Jacek Wolf
2,3#
4
1,5*
, Arkadiusz Szarmach , Pawel J. Winklewski
4
, Edyta
2,3
Szurowska , Krzysztof Narkiewicz
#
TE D
The authors equally contributed to the manuscript
1
Institute of Human Physiology, Medical University of Gdansk, Gdansk, Poland Department of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland 3 Department of Cardiovascular Diseases, International Clinical Research Center, St. Anne’s University Hospital in Brno (FNUSA), Brno, Czech Republic 4 nd 2 Department of Radiology, Medical University of Gdansk, Gdansk, Poland 5 Institute of Health Sciences, Pomeranian University of Slupsk, Slupsk, Poland
AC C
EP
2
*Corresponding author: Pawel Winklewski, M.D., Ph.D. Institute of Human Physiology, Medical University of Gdansk Tuwima Str. 15, 80-210 Gdansk, Poland E-mail:
[email protected]; Tel./Fax: +48 58 3491515
Summary
ACCEPTED MANUSCRIPT
The available studies on cerebrovascular reactivity and cerebral oxygenation in obstructive sleep apnoea (OSA) patients brought conflicting results, yet the overall evidence suggests that resting state cerebral perfusion is diminished in these patients. Interestingly, in a group of healthy
RI PT
professional breath-hold divers who are exercising very long apnoeas - episodes corresponding to the ones observed in patients with OSA - demonstrated that cerebral oxygenation may remain stable at the expense of extreme sympathetic nervous system (SNS) activation.
SC
In the present review we address several mechanisms that could potentially explain these discrepancies. We focus in depth on mechanisms of central SNS reinforcement in OSA including
M AN U
dysfunctional baroreflex response, and inflammatory processes within the brain centres controlling the cardiovascular system. Additionally, novel insights into physiology of cerebral blood flow regulation are proposed, including the role of short-term blood pressure changes, heart rate fluctuations and baroreflex alterations. Finally, a potential role of increased blood flow
TE D
pulsatility in cerebrospinal fluid circulation changes and its influence on SNS drive is highlighted. The presented review provides insights into how sympathetic nervous system reinforcement in OSA promotes maladaptive mechanisms that could alter cerebral perfusion
AC C
EP
regulation, and result in functional and structural cerebral changes.
Key words: obstructive sleep apnoea, cerebral perfusion, functional neuroanatomy, central nervous system, autonomic regulation
ACCEPTED MANUSCRIPT
Abbreviations ASL - arterial spin labelling BBB - blood brain barrier
BOLD-MRI - blood oxygen level dependent magnetic resonance imaging CVLM - caudal ventrolateral medulla CBF - cerebral blood flow CNS - central nervous system
fMRI - functional magnetic resonance imaging
IIH - idiopathic intracranial hypertension IL - interleukin MSNA - muscle sympathetic nerve activity NIRS - Near infrared spectroscopy
M AN U
ICP - intracranial pressure
SC
CO2 - carbon dioxide
NIR-T/BSS - near-infrared transillumination back scattering sounding
TE D
NTS - nucleus of the solitary tract OSA - obstructive sleep apnoea
PVN - paraventricular nucleus of the hypothalamus RVLM - rostral ventrolateral medulla
EP
SaO2 - oxyhaemoglobin saturation
SNS - sympathetic nervous system
SPECT - single-photon emission computed tomography
AC C
TNF-α – tumor necrosis factor α WM – white matter
RI PT
BP - blood pressure
ACCEPTED MANUSCRIPT
Introduction
Obstructive sleep apnoea (OSA) is the most prevalent form of disordered breathing pattern during sleep in adults. Clinical consequences of untreated OSA include not only daily activity
RI PT
impairment but also may confer cardiovascular risk 1 2 3. Screening for sleep apnoea has become a standard in several non-communicable diseases such as hypertension, cardiac arrhythmias or coronary artery disease 4 5 6 7 8. Although the pathogenesis of target organ damage in sleep
SC
apnoea is rather complex including a line of independent factors simultaneously evoked by
morbidity and mortality 9 10.
M AN U
repetitive apnoeas, evidently, the hypoxic stimulus substantially deteriorates cardiovascular (CV)
Repetitive apnoeas, characteristic for OSA, gradually evoke intermittent hypoxia, followed by rapid re-oxygenation upon restoration of breathing. These changes are accompanied by marked alterations in vessel reactivity secondary to sympathetic nervous system (SNS) over-excitation.
TE D
Altogether, these phenomena have the potential to induce ischaemic-, and/or reperfusion-related neural tissue injury 11 12. Untreated OSA patients commonly have depression, anxiety disorders 13 14 15
and significant memory deficits 16 17, which suggests central nervous system malfunction,
EP
especially in autonomic, affective and cognitive regulatory areas 11 High SNS activity is a predominant feature of OSA
19 20 21
18
.
, however, the direct role of
AC C
sympathetic tone on the regulation of cerebral perfusion is a matter of controversy 22 23 24 25 26 12. The link between SNS and cerebral perfusion encompasses several indirect mechanisms including repetitive hypoxia, systemic and central nervous system inflammation, abrupt blood pressure (BP) swings and baroreceptors alternating firing all of which have been reported in untreated OSA 21 27 28 29.
ACCEPTED MANUSCRIPT
Technical developments over the last few years made it possible to considerably progress in our understanding of central nervous system (CNS) structural and functional changes in patients with obstructive sleep apnoea (OSA). However, a variety of new methods employed in this field of
studies in OSA patients
30
RI PT
research produced conflicting results. Additionally, the discrepant results of the morphologic , coincide with even less consistent data on the regulation of cerebral
perfusion in these patients. The latter data usually come from invasive and complex study
SC
techniques with clearly limited repeatability and reproducibility. Due to the overall complexity of the problem, in the following paragraphs a brief characterisation of the concept and methodology the main findings and study
M AN U
of the discussed techniques will be provided along with
contributions to our understanding of the role of OSA in the regulation of cerebral perfusion as well as the pathogenesis of brain malfunction. In this review, we present the most recent data providing novel insights into cerebral oxygenation, perfusion and cerebrovascular reactivity. We
TE D
also discuss the central mechanisms governing SNS discharge in OSA. Additionally, we focus on the novel concepts in the physiological regulation of cerebral blood flow (CBF), pathophysiology of cerebral perfusion in OSA and their clinical consequences. We propose a link between
EP
hypoxia, SNS activation and cerebral perfusion. Finally, future perspectives are outlined with
OSA.
AC C
particular emphasis put on the understanding of altered cerebral blood flow (CBF) regulation in
The presented review provides insights into how sympathetic nervous system
reinforcement in OSA promotes maladaptive mechanisms that could alter cerebral perfusion regulation, and result in functional and structural cerebral changes.
ACCEPTED MANUSCRIPT
Cerebral hemodynamics in OSA Brain circulation in OSA is characterized by marked instability. During apnoeic episodes CBF
RI PT
velocity (CBFV) measured with transcranial Doppler ultrasound may increase by 200%. After restoration of breathing CBFV often drops below the baseline level to finally recover after approximately 60 seconds 31
32 33
. The reported changes in CBF, with subsequent cerebral blood
volume increases, bear a potential to perturb cerebral oxygenation and cerebrovascular reactivity.
SC
Although the problem has been addressed previously, the magnitude of such impairments are controversial with conflicting findings for most of the aspects related to brain perfusion
M AN U
regulation.
Cerebral oxygenation
TE D
Oxygen is critical for neuron metabolism and function (e.g. memory formation). Both, oxygen delivery impairment and oxygen excess immediately result in increased neuron vulnerability
34
.
In the last two decades, cerebral oxygenation was commonly assessed by a near infrared
EP
spectroscopy (NIRS) technique. NIRS allows semi-quantitative or quantitative monitoring of (1) oxygenated haemoglobin (O2Hb), (2) deoxygenated haemoglobin (HHb), (3) total haemoglobin
AC C
(tHb), and (4) O2Hb saturation. Given the fact that the arterial blood volume fraction represents approximately 30% in the human brain
35
, the NIRS technique provides the information on
oxygenation changes occurring mainly within the venous compartment
36
. This fact may be of
importance in the setting of OSA since the NIRS signal is highly dependent on cerebral blood volume, a variable influenced by the duration of apnoea (carbon dioxide (CO2) concentration increases).
ACCEPTED MANUSCRIPT
NIRS studies have consistently shown decreased cerebral oxygenation during apnoea or hypopnea episodes in OSA subjects
37 38
, and cerebral oxygenation was reported to be linked to
the magnitude of decrease of oxyhaemoglobin saturation (SaO2)
38
. The longer the apnoea
RI PT
(usually observed during rapid eye movement sleep) the greater the cerebral deoxygenation documented. However, recent studies based on the infrared light signal processing methodology completed in animal OSA-models produced conflicting results. Almendros et al. 39 suggested that
SC
apnoea was overall associated with increases in brain oxygenation and also oxidative stress. The level of oxidative stress, however, appears to be negatively influenced by advancing age as
M AN U
documented in the rat model 40. Interestingly, increased oxygenation and oxidative stress was not seen in animal models of intermittent hypoxia, with low baseline brain oxygenation
39
. In
addition to differences in applied methods, baseline oxygenation and the age of study subjects, several other factors could possibly explain the reported discrepancies. Apparently, different
TE D
levels of hypercapnia seem to be an important confounding variable. Increasing concentrations of CO2 induce higher oxygen delivery from erythrocytes pial arteriolar bed resistance
42 43 44 45
41
and dilate pial arteries thus decreasing
. In healthy subjects, maximal breath-hold time (high CO2
EP
accumulation) leads to pial artery dilation and subsequent augmentation of CBF 46, an effect that is much less prominent in shorter periods of apnoea or the intermittent hypoxia model 47. Another
AC C
factor which should not be entirely disregarded is the process of adaptation to intermittent hypoxia which is a possible scenario in untreated sleep apnoea or in trained athletes. Long-term conditioning with intermittent hypoxia has been previously described with relation to the heart in animal and human studies 48
49,50 51
. However, the possible role of conditioning with intermittent
hypoxaemia/hypoxia in relation to the CNS remains unclear 52. Nevertheless, recent studies have shown that highly selected groups of elite breath-hold divers are characterised by normal brain oxygenation during even extremely long apnoea periods
53
. Taken together, in light of very
ACCEPTED MANUSCRIPT
limited evidence and discrepant results, the influence of apnoeic episodes on cerebral oxygenation in OSA subjects needs further clarification. However, as for now, the weight of evidence overbalance suggests that cerebral oxygenation is more closely related to apnoeas
RI PT
duration and subsequent changes in CO2 concentration rather than intermittent hypoxia itself.
SC
Cerebrovascular reactivity
Cerebrovascular reactivity may be defined as a vasomotor mechanism modulating CBF through
changes in CO2 concentration 54.
M AN U
constriction and dilation of pre-capillary arterioles in response to a given stimulus, most often
Transcranial Doppler, first described in by Aaslid et al. 55, is a non-invasive ultrasound technique that involves the use of a low-frequency (≤2 MHz) transducer probe to insonate the basal cerebral
TE D
arteries through relatively thin bone windows. Transcranial Doppler is widely used for cerebrovascular reactivity studies as it allows the monitoring of dynamic changes in CBFV and vessel pulsatility over extended time periods with a high temporal resolution. The main drawback
EP
of Doppler-based studies in OSA subjects is that CBF estimation is based on the assumption that changes in CBFV match fluctuations in CBF, i.e. vessel diameter remains constant. In fact,
AC C
cerebral artery diameter may adjust after exposure to different stimuli secondary to repetitive apnoea such as hypercapnia, excess catecholamines or extreme hypoxia 56 57 58 59. Klingelhofer et al.
31
proposed that transient increases in CBFV during apnoeic episodes in OSA
subjects are primarily related to changes in CO2 concentration. In particular, reactivity to CO2 may be increased during REM sleep (maximal recorded CBFV), whereas the reactivity to CO2 remains normal during the wakeful state
31
. Partially in line with these findings are the
ACCEPTED MANUSCRIPT
conclusions by Placidi et al. 60. Authors have suggested that cerebrovascular reactivity to breathholding in OSA subjects follows the normal physiologic pattern but it is a weaker response; it is also diminished after awakening and recovers to normal within several hours of activity
60
.
et al.
61
RI PT
However, recent studies testing the same phenomena produced more conflicting results. Urbano suggested that CO2-dependent reactivity in OSA subjects is normal during the wakeful
state whereas Morgan et al.
62
showed that reactivity to CO2 is blunted both during sleep and in
SC
the wakeful state. Taken together, CO2-related CNS haemodynamic reactivity is rather lower in OSA subjects compared to healthy subjects. Most interestingly, this phenomenon can be
M AN U
normalised after short-term continuous positive airway pressure (CPAP) therapy implying the direct causality of untreated OSA in altered brain vasculature reactivity 63. Functional magnetic resonance imaging (fMRI) utilizes the “BOLD contrast” phenomenon resulting from the differing influences on local image signal intensity of deoxy- vs.
TE D
oxyhemoglobin. Activity associated with peripheral stimulation, task performance or cognitive activity generate a transient increase in regional CBF to match the augmented demands of the active neurons. This augmented CBF is, however, higher than demand for neural tissue oxygen.
EP
As a result, there is a net increase of oxyhemoglobin in the capillary bed, compared to the period prior to the neuronal activity. An elevated oxy-hemoglobin concentration leads to a relative
AC C
decrease in deoxyhemoglobin. Since deoxyhemoglobin, being paramagnetic, is associated with signal loss on T2-weighted images, its transient decrease in concentration is visible as a transient increase in local signal. Consequently, in the capillary bed of tissue closely coupled to the active neurons, signal intensity is increased 64. Local increase in vessel diameters and subsequent CBF elevation is evident in response to breathing a CO2 enriched gas mixture. Thus, as hypercapnia influences local deoxy- vs.
ACCEPTED MANUSCRIPT
oxyhemoglobin concentration changes subsequently a dependent image signal intensity BOLDMRI may be also used as a powerful method to assess cerebrovascular reactivity. Actually, recently published BOLD-MRI-based studies in healthy volunteers who were exposed to gas
complex dynamics in time and space
65 66
RI PT
mixtures of increasing CO2 concentration unveiled that cerebrovascular reactivity is a process of . In line with that, cerebrovascular reactivity changes
observed in a breath-holding BOLD-MRI imaging task study in OSA subjects were neither
SC
homogeneous throughout the brain nor followed vascular territories, but rather corresponded to underlying neuronal networks, suggesting a relationship between cerebrovascular reactivity and 67
. Apparently, the design of cerebrovascular reactivity studies in
M AN U
surrounding neuronal activity
different cohorts (especially in OSA patients) should take into account regional differences, process dynamics, and impact on functional aspects.
TE D
Cerebral perfusion
The brain accounts for 2% of body weight but utilizes about 20% of total cardiac output and oxygen consumption to maintain normal function. Due to high energy consumption cerebral
EP
perfusion is one of the most important parameters defining neurons physiological activity 68.
AC C
Comparison of various studies reporting cerebral perfusion changes in OSA is complicated by a myriad of imaging techniques used for this purpose. Positron emission tomography (PET) imaging is often considered to be the gold standard 69 for measuring perfusion metrics, however single-photon emission computed tomography (SPECT) and computed tomography perfusion are cheaper and provide comparable results 70
71
. Arterial spin labelling (ASL) is another emerging
MRI method for obtaining CBF. ASL is a subtractive technique and generates an image from the difference between the two volumes acquired: one with a magnetic tag applied (achieved by
ACCEPTED MANUSCRIPT
inversion pulses) and the other one without it
72 73
. ASL is the least invasive method because
there is no ionizing radiation involved and no need for an intravenous contrast agent injection. Thus, ASL competes with PET techniques as well as computed tomography and magnetic
RI PT
resonance contrast bolus passage imaging in providing CBF measurements. Nevertheless, ASL still requires certain developments in the standardization to become a method of choice in CBF assessment 74. Importantly, combining either ASL or PET with the T1-weighted MRI voxel-
SC
based morphometry signal-volume optimum normalization may be obtained 75 76.
M AN U
Resting CBF in subjects suffering from OSA seems to persistently decrease both during sleep and wakefulness 77 78. Meyer et al. was the first to report rates of CBF (mL/100g/min.) in OSA subjects using computed tomography-based techniques (utilizing stable xenon and xenon-133). The authors showed a reduction of CBF in OSA patients in the frontal and occipital cortex, pons and cerebellum 77. The decrease in CBF occurred despite relatively greater end-tidal CO2 in
TE D
subjects with OSA versus controls both during wakefulness and sleep (2 mm Hg and 4 mm Hg, respectively) 77. A SPECT study found that severe OSA is associated with reduced CBF in the
EP
parahippocampal gyrus bilaterally, right lingual gyrus, pericentral gyrus, and cuneus 79. ASL perfusion imaging and a voxel-based morphometry study revealed that resting regional
AC C
perfusion was decreased during wakefulness in participants with moderate-to-severe OSA 76. Interestingly, in a study by Baril et al. 80 , which did not confirm regional CBF changes in mild to moderate OSA, the authors reported that participants with severe OSA were characterized by markedly reduced regional CBF compared to controls in several CNS areas (e.g., the magnitude of regional CBF reduction was associated with increased hypopnoea, snoring intensity and magnitude of desaturations, as well as the level of excessive sleepiness). On the other hand, apnoea-, arousal-, and body mass indices positively correlated with increased regional CBF in the
ACCEPTED MANUSCRIPT
basal ganglia, insula, and limbic system 80. It is therefore justified to hypothesize that impaired vascular regulation and reduction in regional CBF may actually result in functional deficits such as cognitive decline. Lower CBF may also facilitate altered neuronal integrity, and/or promote
RI PT
neurodegenerative processes 76 80.
PET allows the measurement of tissue metabolic activity based on regional glucose uptake.
While such examination does not provide a direct information on CBF, glucose metabolism and
SC
CBF are closely correlated and often show similar results 81. In a study by Yaouhi et al. 75 which
M AN U
utilized a combined PET with voxel-based morphometry techniques, a decrease in brain metabolism was limited to the right hemisphere, it was more restricted than the GM density changes, involved the precuneus, the middle and posterior cingulate gyrus, and the parietooccipital cortex, as well as the prefrontal cortex in OSA patients. Thus, the hypometabolic changes included part of the default mode network (precuneus, cingulate areas and inferior
TE D
parietal cortex), the brain system that participates in internal modes of cognition 82. Hypometabolic changes in the prefrontal cortex in subjects with OSA and persistent sleepiness of
AC C
EP
unclear origin were also reported by Antczak et al. 83.
Cerebral hemodynamics in OSA – Practical Points •
Influence of apnoeic episodes on cerebral oxygenation in OSA subjects remains unclear
•
CO2-related brain haemodynamic reactivity is rather lower in OSA subjects
compared to healthy subjects •
Impaired vascular regulation and reduction in regional cerebral blood flow may result in functional deficits
ACCEPTED MANUSCRIPT
Central sympathetic nervous system activity in OSA
RI PT
The rostral ventrolateral medulla (RVLM) is usually considered the main pressor site of the brain, functioning and controlling SNS outflow and reflex mechanisms. Descending projections to the RVLM arise among others from the neurons in the peri-aqueductal grey and hypothalamic
SC
paraventricular nucleus (PVN). The RVLM integrates neural reflex mechanisms from afferent arterial baroreceptors, chemoreceptors and various afferent sensors through direct connection
85
M AN U
with the upper part of the medulla through the nucleus of the solitary tract (NTS) and the PVN 84 .
Peripheral muscle sympathetic nerve activity (MSNA) or skin sympathetic nerve activity (SSNA), may be recorded via a tungsten microelectrode inserted percutaneously into the common
TE D
peroneal nerve, a method known as microneurography. Simultaneously performing a BOLD-MRI of the brain and a microneurography it is possible to functionally identify cortical and subcortical areas involved in the generation of spontaneous fluctuations in sympathetic outflow to muscle or
AC C
EP
skin 86.
Interplay between the central and peripheral sympathetic nervous system in healthy subjects MSNA in healthy subjects is characterised by synchronous bursts 87. Each burst is locked in time to the cardiac cycle through the baroreflex. The MSNA burst aligns with diastole when the BP is relatively low, and hence baroreceptor input is low. The nucleus of the solitary tract (NTS) is the primary receiving area of inputs from the arterial baroreceptors. The NTS sends excitatory
ACCEPTED MANUSCRIPT
projections to the caudal ventrolateral medulla (CVLM), which exerts tonic inhibitory control of the RVLM, the primary output nucleus responsible for sympathetic vasoconstrictor control of arterial pressure 88
89
. Simultaneous recording of the MSNA signal along with brain a BOLD-
RI PT
MRI allows depiction of the baroreflex neural loop in real time. The time-dependant fluctuations in BOLD-MRI signal intensity within the NTS, CVLM and RVLM correlate with the
spontaneous fluctuations in MSNA in humans at rest 90. Furthermore, functional connectivity
SC
analysis suggests that activity within higher cortical regions, such as the insula, dorsolateral
sympathetic neurons in the RVLM 91.
M AN U
prefrontal cortex and hypothalamus, may regulate resting MSNA by projections to the premotor
Interplay between the central and peripheral sympathetic nervous system in OSA subjects
92 20 21 27
TE D
It is now well-established that OSA is associated with a significantly increased resting MSNA 19 and dampened baroreflex 92 27. Despite the fact that experimental animal studies
revealed that brainstem nuclei are critical for the generation and modulation of resting
EP
sympathetic outflow 93 94, analogous human data have become available only very recently. During wakeful state, OSA subjects display a significantly lower BOLD-MRI signal intensity
AC C
compared with matched-controls in the region of the medullary raphe nuclei, left RVLM, right and left dorsolateral pons as well as right midbrain in the region of the periaqueductal grey matter. Importantly, an elevated resting MSNA commonly recorded in OSA subjects is not paralleled by an increased BOLD-MRI signal intensity within the region of the RVLM. Oxygen level dependent signalling appears to reflect intensity of synaptic activity rather than neural electrical output 95. Therefore, a decrease in signal intensity within the RVLM in OSA patients
ACCEPTED MANUSCRIPT
may actually represent a reduction in active inhibition of the RVLM (Figure 1). Taken together, the elevated sympathetic drive in OSA may result from functional changes within discrete regions of the human brainstem, including the dorsolateral pons, RVLM and medullary raphe.
RI PT
These brainstem regions are known to modulate sympathetic output via either direct or indirect inputs to the sympathetic preganglionic neurons in the spinal cord 96. As documented, six months of CPAP treatment significantly reduces MSNA in subjects with OSA, an effect that is sustained
SC
for at least twelve months 21 28 97. Importantly, MSNA-coupled changes in BOLD-MRI signal intensity recorded in wakeful subjects within the dorsolateral pons, medullary raphe, and rostral
M AN U
ventrolateral medulla return to control levels. That is, CPAP application reverses brain stem functional changes associated with elevated MSNA in OSA subjects 98 97. Higher centres involved in cardiovascular control may be also affected in the course of untreated sleep apnoea, as suggested by associations between increased MSNA and BOLD-MRI signalling
TE D
recorded in wakeful OSA-subjects within several structures such as left and right dorsolateral and medial prefrontal cortices, dorsal precuneus, anterior cingulate cortex, retrosplenial cortex and caudate nucleus. Another alteration seen in sleep apnoea refers to the right
EP
hippocampus/parahippocampus where BOLD-MRI signal intensity decreases significantly in
AC C
controls but does not change in OSA 99. Quite surprisingly, authors reported that changes in BOLD-MRI signal intensity associated with increased MSNA did not coincide with regional structural changes in individuals with OSA 99. Following six months of CPAP-treatment the reduction in resting MSNA is coupled with significant drops in signal intensity in the precuneus bilaterally, left and right insula, right medial prefrontal cortex, right anterior cingulate cortex, right parahippocampus and left and right retrosplenial cortices. These data further support the
ACCEPTED MANUSCRIPT
concept that functional changes in these suprabulbar sites are driving the augmented sympathetic outflow (via projections to the brainstem) to the muscle vascular bed in untreated OSA 100.
RI PT
The possible limitation of the reviewed research testing the interplay between central and peripheral sympathetic nervous systems in healthy and OSA subjects is that all of the presented studies were based on one-site data, therefore their replication is still awaited. Yet, the concept of bringing BOLD-MRI and MSNA together seems compelling and may enormously advance our
M AN U
SC
knowledge in this field.
Inflammatory changes within the brain structures controlling sympathetic nervous system outflow Systemic inflammation (including increased levels of TNF-α and IL-6) 101 102, and reninangiotensin-aldosteron system activation 103 104 constitute an important part of OSA pathogenesis.
TE D
Pro-inflammatory cytokines produced in the periphery are capable of penetrating the blood brain barrier (BBB) at points of increased permeability and/or disruption, and thus have the potential to influence the function of the various structures in the CNS. In fact, in animals the stimulation of
EP
PVN with TNF-α and IL-1β results in augmented adrenocorticotropic hormone release, increased
AC C
sympathetic outflow and an enhanced cardiac sympathetic afferent reflex with subsequent BP elevation 105 106 107. Pro-inflammatory cytokines are also produced by glia and neurons, and the recently identified brain inflammatory response to peripheral inflammation may further contribute to the development of hypertension 108 109 110 111. Interestingly, circulating angiotensin II may influence NTS neuronal networks across the BBB 112, contributing to BBB disruption 113 114 115
, and subsequently gain access to brain areas that are normally protected by the BBB,
including the PVN, RVLM, and NTS 116 (Figure 2). Additionally, pro-inflammatory cytokines
ACCEPTED MANUSCRIPT
(IL-1β, IL-6 and TNF-α) may cause dysregulation of adherens and tight junctions leading to BBB permeability 117 118. Angiotensin II and pro-inflammatory cytokines are critical for the development of an inflammatory state within the forebrain and hindbrain nuclei resulting in
RI PT
augmented sympathetic outflow to the periphery 108 109 29. Alternatively, oxidative stress
generated during apnoeic episodes may trigger inflammatory changes in PVN and stimulate SNS outflow 119 120 121 39.
SC
Despite a sound theoretical concept supporting existence of brain inflammation in OSA
M AN U
experimental data related to neuroinflammatory changes in OSA is scarce. Cyclooxygenase-2 (COX-2), TNF-α, IL-1b and IL-6 mRNA is elevated in microglia isolated from cortex, medulla and spinal cord tissues dissected from rats exposed to chronic intermittent hypoxia (animal model of OSA) compared to control animals 122. The study, however, did not provide specific
TE D
information related to PVN, RVLM or NTS, the brain structures responsible for SNS activity. The recent study by Chen et al. was the first that attempted to link intracranial white matter (WM) integrity and circulating inflammatory markers in subjects with OSA 123. In this study
EP
diffusion tensor imaging (DTI) was used, an MRI sequence that is more sensitive for detecting intracranial microstructural change than a T1-weighted MRI. Taking pixel-by-pixel information
AC C
on diffusion anisotropy, the technique allows the visualisation of the pathway of WM tracts through the brain 64. In subjects with severe OSA, WM damage was associated with disease severity (indicated by apnoea–hypopnoea and desaturation indices), decreased O2 saturation and systemic inflammation (indicated by leukocyte early apoptosis) 123. This in turn, may partly explain neurocognitive impairment observed in OSA-patients which has been documented to be correlated to oxidative stress 124.
ACCEPTED MANUSCRIPT
Finally, biochemical markers of inflammation were assessed in thalamus and putamen in a small group of subjects with mild to severe OSA 125. A study based on a modified resonance spectroscopy - a noninvasive neuroimaging technique, which allowed for the assessment of
RI PT
cerebral metabolite changes, providing information on neuronal cellular viability, cellular energetics, and cellular membrane status was used 126. Subjects with OSA showed
neurochemical changes in the thalamus and putamen suggestive of substantial microglia
SC
activation, and the presence of mild neurodegenerative processes 125. Similar changes were
M AN U
reported in insula by the same group 127.
Taken together, neuroinflammation and oxidative stress in brain centres responsible for SNS outflow provide an interesting conceptual substrate to explain, at least partially, central sympathetic reinforcement in OSA. Although a direct mechanism linking OSA with brain inflammation has not yet been established there is solid theoretical background and limited direct
TE D
evidence supporting the hypothesis that such an association may exist.
•
EP
Central sympathetic nervous system activity in OSA – Practice Points Elevated sympathetic drive in OSA corresponds to functional changes within
•
AC C
discrete regions of the human brainstem Higher centres involved in cardiovascular control are implicated in the augmented
sympathetic outflow (via projections to the brainstem) in OSA
•
Inflammatory changes within brain structures responsible for autonomic control
may further enhance central sympathetic outflow in OSA
ACCEPTED MANUSCRIPT
Novel concepts questioning the current paradigm on cerebral blood flow control in OSA Recent decades produced several scientific discoveries that challenged our knowledge on CBF
RI PT
control in humans. The comprehensive research on CBF tested several aspects including the concept of “cerebral autoregulation”, cardiac compensatory mechanisms and the impact of
SC
pulsatility ICP changes on brain perfusion regulation.
M AN U
Cerebral autoregulation
Throughout several decades the explanation of CBF regulation was to a certain extent arbitrary as several unsolved issues existed. In short, CBF was regarded to be entirely unaffected by systemic BP within the systolic BP range of approximately 60 to 150 mm Hg 128. The Lassen’s concept that the plateau region within the so-called “autoregulatory range” has a slope of zero has had
TE D
considerable influence on the static assessment of cerebral autoregulation in physiologic and clinical studies. However, in 2010 Lucas et al. reported systematic changes in CBF and cerebral oxygenation over a wide range of pharmacologically-induced BP alterations in healthy subjects . CBF changed by approximately 8% per each 10 mm Hg fluctuation in systemic BP for
EP
129
AC C
subjects with both hypotension and hypertension 130. These findings clearly show that, at least in healthy subjects, the slope between CBF and BP is relatively linear. Assuming that changes in peripheral BP represents an important mechanism to match temporal brain oxygen demand then BP surges following apnoeic episodes could be interpreted from a different perspective. In elite breath-hold divers exercising very long apnoeas, SaO2 saturation may drop by 40% while brain oxygenation remains stable, at a cost of a BP surge by 50-60% and a CBFV increase by over 100% 53. Therefore, a high sympathetic drive and subsequent BP rise
ACCEPTED MANUSCRIPT
may be perceived as a trade-off between the immediate need to meet neurons oxygen demand and longer-term stability of the cardiovascular system (increased risk of cardiovascular and cerebrovascular events). Interestingly, SNS activation produce spleen contractions, resulting in
RI PT
red blood cells autotransfusion and facilitating oxygen transport 131 132 133 134 the phenomenon recently confirmed also in OSA subjects 135. Taken together, during hypoxia an increase in
sympathetic outflow may represent an adaptive mechanism to stabilize oxygen supply to brain
SC
(Figure 3).
M AN U
Owing to cyclical performance of the heart as a pump, in the aorta and the proximal part of the arterial vascular tree blood flow is characterized by a pulsatile flow. The aorta which consists of a substantial amount of elastic tissue, acts as a temporal buffer for blood during the ejection phase of the heart (Windkessel function), and effectively tends to reduce its afterload. Consequently,
TE D
from the thoracic aorta to the end of the arterioles, pulsatility is progressively attenuated 136. Tzeng et al. 130 indicated that CBF dynamics during acute transient hypotension and hypertension is dominated by cerebrovascular Windkessel properties independent of cerebral autoregulation.
EP
Furthermore, haemodynamic effects of hypercapnia during transient BP challenges primarily reflect changes in Windkessel properties rather than pure cerebral autoregulatory impairment 130.
AC C
A repeatedly reported increased OSA-related arterial stiffness which has been demonstrated using different pulse wave analysis techniques suggests that the buffering capacities of the aorta is deteriorated in these patients 137 138. The diminished Windkessel function of large arteries may be of particular importance (esp. in the setting of concomitant SNS overdrive) as marked BP surges coupled with apnoeas are transmitted to target organs without sufficient buffering, conceivably negatively influencing morbidity and mortality of OSA-patients.
ACCEPTED MANUSCRIPT
Importantly, brain blood volume and its oxygenation changes (measured by global BOLD-MRI signal) evoked by peripheral SNS activation (using handgrip and cold pressor tests) are blunted in OSA patients compared to healthy controls 139. Thus, dysregulation of the SNS system in OSA
RI PT
affects cerebral perfusion adaptive responses to external stressors. This finding also suggests that CBF regulation mechanisms in OSA are much more complex than the traditional “cerebral autoregulation” concept.
SC
Lastly, scientific perspective allows the hypothesis that if a finite slope of the plateau region in
M AN U
the so called “autoregulation curve” does not necessarily imply defective autoregulation in healthy subjects, all clinical studies reporting cerebral autoregulation impairment in OSA subjects should be viewed with caution. The topic should then be re-examined and the comparison of the
TE D
slopes in well-matched groups of healthy and OSA patients should be performed.
Baroreflex and cardiac contribution to cerebral blood flow control Georgiadis et al. 140 was the first to demonstrate a long-term brain microcirculation adaptation to
EP
decreased cardiac output in patients with chronic left ventricle failure. Ogoh et al. 141 showed that
AC C
the cardiac baroreflex plays an important role in the dynamic CBF regulation during acute transient hypotension in healthy subjects. The latest finding was further strengthened by our report suggesting that the baroreflex influences the pial artery response to rapid BP changes 46. The baroreflex and cardiac contribution to the regulation of CBF has profound implications for our understanding of the mechanisms leading to impaired CBF control in OSA subjects. Urbano et al. 61 reported that cerebral autoregulation is impaired in OSA subjects based on the observation that BP and CBF responses to orthostatic tests are delayed in comparison to healthy
ACCEPTED MANUSCRIPT
subjects. The described impairment may be partially explained by a damped baroreflex 92 27, and blunted heart rate response 142 in OSA. Interestingly, the cardiac contribution to the relationship between BP and pial artery oscillations in healthy subjects is negatively affected by apnoea,
RI PT
hypoxia and increased respiratory resistance 47 46 143 144, and it may be additionally modified by the SNS 145 146. Clearly, the discussed findings warrant further integrated studies to better understand the complexity of these mechanisms in OSA-patients.
SC
A hypothesis that baroreflex and cardiac output play an important role in regulation of cerebral
M AN U
perfusion is now justified; therefore the central SNS reinforcement (as referred to in the above sections) may be of critical significance for the whole system homeostasis and pathogenesis of target organ damage including the brain itself. Various imaging studies consequently show a reduction in the regional perfusion, particularly in subjects with severe OSA. Thus, over-activity of brain regions governing SNS discharge may be perceived as an adaptive mechanism to
TE D
increase CBF, constituting at the same time a vicious circle in OSA-related pathological
EP
processes.
AC C
Pulse wave encephalopathy
The concept of pulse wave encephalopathy has been initially proposed by the Bateman group 147. Pulsatile flow may be considered a manifestation of the energy stored in the form of the pulse pressure which is dampened by shifting cerebrospinal fluid and venous blood to ensure nonpulsatile continuous perfusion through the capillary bed 147. If dampening of the pulsation energy becomes ineffective, as it may be observed in the impaired venous outflow or increased ICP, it results in an increased pial artery pulsation 147 . Exposure to high pulsatile pressure and
ACCEPTED MANUSCRIPT
augmented flow per se is a well-known predictor of cerebral vascular damage, even in the absence of increases in mean BP 148 149 150. High arteriolar pulsatility observed during apnoeas in healthy subjects may potentially provide a mechanistic explanation for the higher risk of
RI PT
cerebrovascular events in OSA subjects 144. Increased arterial pulsatility may augment
perivascular shear stress and lead to accumulated damage to perivascular oligodendrocytes, resulting in microstructural changes in white matter and contributing to proliferation of
SC
leukoaraiosis over time 151. The study by Jolly et al. establishes a potential causal link between
M AN U
pulse wave encephalopathy and WM abnormalities in OSA 151.
It is important to underline that changes in cardiac driven arterial flow pulsatility also affect cerebrospinal fluid dynamics. Association between WM lesion formation and increased cerebrospinal fluid pulsatility has been initially reported in subjects with multiple sclerosis 152. Cerebrospinal fluid flow quantification in the aqueduct of Sylvius was performed with a cine
TE D
phase contrast MRI, while WM changes were assessed using T2-weighted MRI imaging. Recently the same group reported that in individuals without neurologic diseases, WM lesions formation appear to be associated with both hypertension and augmented cerebrospinal fluid
EP
pulsatility, rather than ageing per se 153.
AC C
The near-infrared transillumination-backscattering sounding (NIR-TBSS) implemented by our group may be considered (for explanatory purposes) a modified NIRS methodology (described in detail in the above section). To wit, the distance between emitter and detector of infrared light in NIR-TBSS is very small, thus enabling assessment of the width of subarachnoid space filled with cerebrospinal fluid instead of oxygenated / deoxygenated haemoglobin in the brain 154 155. Association between changes in subarachnoid space width measured with NIR-T/BSS and T1weighted MRI has been proven experimentally 156. Our recent results indicate that apnoea in
ACCEPTED MANUSCRIPT
healthy subjects is associated with large swings in the width of the subarachnoid space 46, thus suggesting substantial cerebrospinal fluid shifts. Taking the Jennum and Borgessen study 157, reporting ICP increases during apnoeic episodes in OSA, together with Beggs and Bateman’s
RI PT
observations, it is justify to assume that pulse wave encephalopathy might be of clinical relevance in OSA. Unfortunately, this hypothesis needs to be further verified in properly-designed studies
SC
as there is virtually no data available on this topic in OSA subjects.
M AN U
Intracranial pressure and idiopathic intracranial hypertension
In the late eighties, Jennum and Borgessen 157 demonstrated that ICP increases during apnoeic episodes in OSA subjects, and the differences in ICP correlated with systemic BP fluctuations. Several authors postulated that OSA may play a role in the development of idiopathic intracranial
TE D
hypertension (IIH) 158 159 160. It has been proposed that the increases in ICP may result in compression of the cerebral venous sinuses, giving rise to transverse venous sinus stenosis which in turn facilitates persistent elevations of ICP, and thus IIH 160 161. However, the major
EP
methodological limitation of all the aforementioned studies is the lack of an IIH-free control group. Only one retrospective study performed on 24 newly diagnosed IIH-patients aimed to
AC C
compare sleep apnoea status (prevalence and severity) with IIH-free sample subjects from the general population matched for age, sex, race, body mass index, and sex/hormonal status. Based on this model, those authors concluded that OSA is not an independent risk factor for IIH 162. Given the small number of men included in the Thurtell et al. study 162, further investigation is warranted to see whether or not OSA is a risk factor for IIH in men. This may be of particular importance as the prevalence of OSA is reported to be 2-3 times higher in men than in women 163.
ACCEPTED MANUSCRIPT
Larger, prospective and controlled studies are necessary to further evaluate the relationship between OSA and IIH, with special emphasis put on the effects of OSA treatment upon the
RI PT
clinical course of IIH. Cushing was the first to demonstrate in animal study that substantial (50-100 mmHg) increases in ICP were associated with matching elevations in arterial pressure, the response being widely known as the so-called Cushing triad (irregular breathing, bradycardia, and severe arterial
SC
hypertension) 164. Later studies have shown BP surges resulting from much smaller ICP increases
M AN U
in humans 165 166. Recent studies support the concept that incremental changes in ICP may result in SNS activation and subsequent BP rise 167. The potential bidirectional link between ICP and SNS fluctuations during apnoeic episodes represents another field for research in OSA that
TE D
requires attention.
Cerebral blood flow regulation in OSA – Practical Points •
SNS activation during apnoeic episodes likely represent adaptive mechanism to
•
EP
stabilize cerebral oxygenation
Central SNS reinforcement, with subsequent hypertension, may represent adaptive mechanism to counterbalance decreased cerebral perfusion in OSA subjects Abnormal arterial, venous and cerebrospinal fluid pulsatility may result in brain
AC C
•
structural impairments in OSA
•
Role of OSA in the development of idiopathic intracranial hypertension, and the link
between intracranial pressure fluctuations and SNS activation have yet to be determined
ACCEPTED MANUSCRIPT
Perspectives Evidently, OSA affects multiple neural pathways and controlling centres which finally promotes
RI PT
high SNS activity as a predominant feature. There is a rationale that SNS augmented tone in OSA largely represents an adaptive response, counteracting intermittent hypoxic episodes and gradual cerebral perfusion declines characteristic for OSA (Figure 3). Although successful treatment of sleep-disordered breathing have a rather modest BP lowering potential 168, the hypotensive effect
SC
is most likely driven by diminished SNS activity. Reversal of central functional impairments and
M AN U
normalization of brain vasculature reactivity with CPAP treatment reinforce the significance of breathing pattern restoration as a clinical target in OSA, supporting the concept that the CPAPrelated benefit goes beyond sheer BP decrease.
In summary, a better understanding of the intriguing link between the central SNS outflow and
TE D
CBF control may open new fields for translation of scientific excellence into clinical applications. Functional BOLD-MRI is one of the most promising tools in such research, although it still suffers from relatively low-time resolution. Multi-signal data acquisition,
EP
combined with advanced mathematical methods which take into account the complexity of the brain and cardiovascular haemodynamics, represents the most promising network capable of
AC C
describing the interrelations and pathways involved in CBF control which is characteristic for sleep apnoea patients. Additionally, new methods allowing for non-invasive estimation of ICP and high temporal resolution offer additional value in OSA research.
ACCEPTED MANUSCRIPT
Research Agenda •
Cardiac and baroreflex contribution to cerebral blood flow control in OSA requires further investigations The link between central sympathetic nervous system activity and cerebral blood
RI PT
•
flow control has yet to be clarified •
Sufficiently powered, prospective and controlled studies are needed to evaluate the relationship between OSA and idiopathic intracranial pressure
Multi-signal data acquisition and advanced mathematical methods represents a
SC
promising approach to understand the complexity of the brain and cardiovascular
EP
TE D
M AN U
haemodynamics in OSA
AC C
•
ACCEPTED MANUSCRIPT
Source of funding Drs. Jacek Wolf, and Krzysztof Narkiewicz are supported by the European Regional
RI PT
Development Fund - Project FNUSA-ICRC (No. CZ.1.05/1.1.00/02.0123); by the REGPOT ICRC-ERA Human Bridge grant No. 316345 provided by the EU; and by the NCN-grant „Hypertension and cerebrovascular dysfunction: contribution of neuroanatomical connectivity,
SC
sympathetic nervous system and cardiovascular risk factors”, UMO-2011/02/A0NZ5/00329.
M AN U
Conflict of interest
Drs. Jacek Wolf, and Krzysztof Narkiewicz received fees for lectures on sleep apnoea from
AC C
EP
TE D
ResMed.
ACCEPTED MANUSCRIPT
Figures Figure 1 Blood pressure increase results in augmented baroreceptor input, and subsequently
RI PT
higher activity of both the NTS and CVLM. This is in contrast with lower RVLM activity because of the inhibition provided by the CVLM. A decrease in BOLD-MRI signal intensity within the RVLM in OSA patients may actually represent a reduction in active inhibition of the
SC
RVLM by the CVLM. As a consequence SNS outflow from RVLM is augmented.
BP – blood pressure; BOLD-MRI - blood oxygen level dependent - magnetic resonance imaging;
M AN U
CVLM - caudal ventrolateral medulla; NTS - nucleus of the solitary tract; OSA – obstructive sleep apnoea; RVLM - rostral ventrolateral medulla, SNS – sympathetic nervous system.
Figure 2 Angiotensin II, IL-1β, IL-6 and TNF-α contribute to BBB disruption and subsequently
TE D
gain access to the PVN that is normally protected by the BBB. The hypothalamic PVN is a pivotal centre within the brain neuronal circuitry involved in the maintenance of homeostasis. Stimulation of the PVN with angiotensin II, IL-1β, IL-6 and TNF-α results in augmented
EP
generation of SNS outflow via projections to the RVLM. BBB - blood brain barrier; IL – interleukin; PVN - paraventricular nucleus of the hypothalamus;
factor
AC C
RVLM - rostral ventrolateral medulla; SNS – sympathetic nervous system; TNF – tumor necrosis
Figure 3 SNS activation as an adaptive mechanism in response to hypoxic episodes. Hypertension and increased blood flow pulsatility may be considered as bystander effects (consequence of trade-off between matching immediate brain oxygen demand and longer-term
ACCEPTED MANUSCRIPT
cardiovascular system dysregulation). Hypertension leads to systemic inflammation and RAAS activation, and further reinforcement of central SNS discharge. Increased blood flow pulsatility results in pulse wave encephalopathy and white matter damage. Potential link between
RI PT
intracranial pressure and SNS fluctuations has yet to be clarified. Yet, the evidence shows that normal breathing restoration ameliorates SNS overactivity in OSA patients.
OSA – obstructive sleep apnoea; RAAS – renin-angiotensin-aldosterone system; SNS –
AC C
EP
TE D
M AN U
SC
sympathetic nervous system
ACCEPTED MANUSCRIPT
References Parati G, Lombardi C, Hedner J, et al. Position paper on the management of patients with obstructive sleep apnea and hypertension: joint recommendations by the European Society of Hypertension, by the European Respiratory Society and by the members of European COST (COoperation in Scientific and Technological research) ACTION B26 on obstructive sleep apnea. J Hypertens. 2012;30(4):633-646.
RI PT
1.
* Position paper on the management of patients with comorbid sleep apnea and hypertension
4. 5.
TE D
6.
SC
3.
Randerath WJ, Hein H, Arzt M, et al. Konsensuspapier zur Diagnostik und Therapie schlafbezogener Atmungsstörungen bei Erwachsenen. Somnologie Schlafforschung und Schlafmedizin. 2014;18(1):34-52. Positionspapier zur Diagnostik und Therapie schlafbezogener Atmungsstörungen bei Erwachsenen. Somnologie - Schlafforschung und Schlafmedizin. 2014;18(1):53-57. Fox H, Bitter T, Horstkotte D, Oldenburg O. Sleep-Disordered Breathing and Arrhythmia in Heart Failure Patients. Sleep Med Clin. 2017;12(2):229-241. Fox H, Bitter T, Horstkotte D, Oldenburg O. Cardioversion of atrial fibrillation or atrial flutter into sinus rhythm reduces nocturnal central respiratory events and unmasks obstructive sleep apnoea. Clin Res Cardiol. 2016;105(5):451-459. Somers VK, White DP, Amin R, et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol. 2008;52(8):686-717.
M AN U
2.
8.
9.
10.
Tykarski A, Narkiewicz K, Gaciong Z, et al. 2015 guidelines for the management of hypertension. Recommendations of the Polish Society of Hypertension - short version. Kardiol Pol. 2015;73(8):676-700. Fox H, Purucker HC, Holzhacker I, et al. Prevalence of Sleep-Disordered Breathing and Patient Characteristics in a Coronary Artery Disease Cohort Undergoing Cardiovascular Rehabilitation. J Cardiopulm Rehabil Prev. 2016;36(6):421-429. Tkacova R, McNicholas WT, Javorsky M, et al. Nocturnal intermittent hypoxia predicts prevalent hypertension in the European Sleep Apnoea Database cohort study. Eur Respir J. 2014;44(4):931-941. Oldenburg O, Wellmann B, Buchholz A, et al. Nocturnal hypoxaemia is associated with increased mortality in stable heart failure patients. Eur Heart J. 2016;37(21):1695-1703.
AC C
7.
EP
* Practical guidelines for the management with cardiovascular disease patients with comorbid sleep apnea
ACCEPTED MANUSCRIPT
15.
16.
17.
18.
19.
20.
EP
21.
RI PT
14.
SC
13.
M AN U
12.
Harper RM, Kumar R, Macey PM, Ogren JA, Richardson HL. Functional neuroanatomy and sleep-disordered breathing: implications for autonomic regulation. Anat Rec (Hoboken). 2012;295(9):1385-1395. Winklewski PJ, Frydrychowski AF. Cerebral blood flow, sympathetic nerve activity and stroke risk in obstructive sleep apnoea. Is there a direct link? Blood Press. 2013;22(1):27-33. Berry DT, Webb WB, Block AJ, Bauer RM, Switzer DA. Nocturnal hypoxia and neuropsychological variables. J Clin Exp Neuropsychol. 1986;8(3):229-238. Bedard MA, Montplaisir J, Richer F, Rouleau I, Malo J. Obstructive sleep apnea syndrome: pathogenesis of neuropsychological deficits. J Clin Exp Neuropsychol. 1991;13(6):950-964. Sforza E, de Saint Hilaire Z, Pelissolo A, Rochat T, Ibanez V. Personality, anxiety and mood traits in patients with sleep-related breathing disorders: effect of reduced daytime alertness. Sleep Med. 2002;3(2):139-145. Ferini-Strambi L, Baietto C, Di Gioia MR, et al. Cognitive dysfunction in patients with obstructive sleep apnea (OSA): partial reversibility after continuous positive airway pressure (CPAP). Brain Res Bull. 2003;61(1):87-92. Felver-Gant JC, Bruce AS, Zimmerman M, Sweet LH, Millman RP, Aloia MS. Working memory in obstructive sleep apnea: construct validity and treatment effects. J Clin Sleep Med. 2007;3(6):589-594. Rosenzweig I, Glasser M, Polsek D, Leschziner GD, Williams SC, Morrell MJ. Sleep apnoea and the brain: a complex relationship. Lancet Respir Med. 2015;3(5):404-414. Carlson JT, Hedner J, Elam M, Ejnell H, Sellgren J, Wallin BG. Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest. 1993;103(6):1763-1768. Hedner J, Darpo B, Ejnell H, Carlson J, Caidahl K. Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications. Eur Respir J. 1995;8(2):222-229. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995;96(4):1897-1904.
TE D
11.
22.
23. 24.
25.
AC C
** Real-time microneurographical recordings showing sympathetic firing during apneic episodes
Ogoh S. Comments on Point:Counterpoint: Sympathetic activity does/does not influence cerebral blood flow. Autonomic nervous system influences dynamic cerebral blood flow. J Appl Physiol (1985). 2008;105(4):1370. Ogoh S, Ainslie PN. Cerebral blood flow during exercise: mechanisms of regulation. J Appl Physiol (1985). 2009;107(5):1370-1380. van Lieshout JJ, Secher NH. Point:Counterpoint: Sympathetic activity does/does not influence cerebral blood flow. Point: Sympathetic activity does influence cerebral blood flow. J Appl Physiol (1985). 2008;105(4):1364-1366. Seifert T, Secher NH. Sympathetic influence on cerebral blood flow and metabolism during exercise in humans. Prog Neurobiol. 2011;95(3):406-426.
ACCEPTED MANUSCRIPT
27.
28.
ter Laan M, van Dijk JM, Elting JW, Staal MJ, Absalom AR. Sympathetic regulation of cerebral blood flow in humans: a review. Br J Anaesth. 2013;111(3):361-367. Narkiewicz K, Pesek CA, Kato M, Phillips BG, Davison DE, Somers VK. Baroreflex control of sympathetic nerve activity and heart rate in obstructive sleep apnea. Hypertension. 1998;32(6):1039-1043. Narkiewicz K, Kato M, Phillips BG, Pesek CA, Davison DE, Somers VK. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation. 1999;100(23):2332-2335.
RI PT
26.
Winklewski PJ, Radkowski M, Wszedybyl-Winklewska M, Demkow U. Brain inflammation and hypertension: the chicken or the egg? J Neuroinflammation. 2015;12:85.
M AN U
29.
SC
* study demonstrated decreased peripheral sympathetic nervous system tone in resposnse to OSA reversal
** Inflammation of forebrain and hindbrain nuclei controlling the sympathetic nervous system efferent transmission from the brain to the periphery seems to constitute a key element in the development of neurogenic hypertension. The authors suggest that reninangiotensin-driven hypertension encompasses feedback and feedforward mechanisms in the development of neurogenic hypertension while low-intensity, chronic peripheral inflammation of any origin may serve as a model of a feedforward mechanism in this condition
32. 33. 34. 35. 36.
37.
TE D
EP
31.
Celle S, Delon-Martin C, Roche F, Barthelemy JC, Pepin JL, Dojat M. Desperately seeking grey matter volume changes in sleep apnea: A methodological review of magnetic resonance brain voxel-based morphometry studies. Sleep Med Rev. 2016;25:112-120. Klingelhofer J, Hajak G, Sander D, Schulz-Varszegi M, Ruther E, Conrad B. Assessment of intracranial hemodynamics in sleep apnea syndrome. Stroke. 1992;23(10):1427-1433. Balfors EM, Franklin KA. Impairment of cerebral perfusion during obstructive sleep apneas. Am J Respir Crit Care Med. 1994;150(6 Pt 1):1587-1591. Yaggi H, Mohsenin V. Obstructive sleep apnoea and stroke. Lancet Neurol. 2004;3(6):333-342. Massaad CA, Klann E. Reactive oxygen species in the regulation of synaptic plasticity and memory. Antioxid Redox Signal. 2011;14(10):2013-2054. Ito H, Kanno I, Fukuda H. Human cerebral circulation: positron emission tomography studies. Ann Nucl Med. 2005;19(2):65-74. Ferrari M, Quaresima V. A brief review on the history of human functional nearinfrared spectroscopy (fNIRS) development and fields of application. Neuroimage. 2012;63(2):921-935. Hayakawa T, Terashima M, Kayukawa Y, Ohta T, Okada T. Changes in cerebral oxygenation and hemodynamics during obstructive sleep apneas. Chest. 1996;109(4):916-921.
AC C
30.
ACCEPTED MANUSCRIPT
42.
43.
44.
45.
46.
RI PT
41.
SC
40.
M AN U
39.
Valipour A, McGown AD, Makker H, O'Sullivan C, Spiro SG. Some factors affecting cerebral tissue saturation during obstructive sleep apnoea. Eur Respir J. 2002;20(2):444-450. Almendros I, Farre R, Planas AM, et al. Tissue oxygenation in brain, muscle, and fat in a rat model of sleep apnea: differential effect of obstructive apneas and intermittent hypoxia. Sleep. 2011;34(8):1127-1133. Dalmases M, Torres M, Marquez-Kisinousky L, et al. Brain tissue hypoxia and oxidative stress induced by obstructive apneas is different in young and aged rats. Sleep. 2014;37(7):1249-1256. Jensen FB. The dual roles of red blood cells in tissue oxygen delivery: oxygen carriers and regulators of local blood flow. J Exp Biol. 2009;212(Pt 21):33873393. Domoki F, Zimmermann A, Toth-Szuki V, Busija DW, Bari F. Acetazolamide induces indomethacin and ischaemia-sensitive pial arteriolar vasodilation in the piglet. Acta Paediatr. 2008;97(3):280-284. Narayanan N, Leffler CW, Daley ML. Influence of hypercapnic vasodilation on cerebrovascular autoregulation and pial arteriolar bed resistance in piglets. J Appl Physiol (1985). 2008;105(1):152-157. Frydrychowski AF, Wszedybyl-Winklewska M, Guminski W, Lass P, Bandurski T, Winklewski PJ. Effects of acute hypercapnia on the amplitude of cerebrovascular pulsation in humans registered with a non-invasive method. Microvasc Res. 2012;83(2):229-236. Frydrychowski AF, Winklewski PJ, Szarmach A, Halena G, Bandurski T. Nearinfrared transillumination back scattering sounding--new method to assess brain microcirculation in patients with chronic carotid artery stenosis. PLoS One. 2013;8(4):e61936. Wszedybyl-Winklewska M, Wolf J, Swierblewska E, et al. Pial artery and subarachnoid width response to apnoea in normal humans. Journal of Hypertension. 2015;33(9):1811-1818.
TE D
38.
47.
AC C
EP
** The pial artery and intracranial pressure affected by, and actively respond to blood pressure changes evoked by apnoea. Baroreflex and intracranial pressure changes are involved in a complex and intricate mechanism aiming at the stabilization of cerebral blood flow Wszedybyl-Winklewska M, Wolf J, Swierblewska E, et al. Acute hypoxia diminishes the relationship between blood pressure and subarachnoid space width oscillations at the human cardiac frequency. PLoS One. 2017;12(2):e0172842. ** It has been demonstrated that cerebral haemodynamics was relatively stable during a very short exposure to poikilocapnic hypoxia. However, changes in cardiac performance directly affected oscillations in the subarachnoid space width. Abnormal subarachnoid width oscillations suggest a disturbed cerebrospinal fluid pulsatility pattern. Consequently, the study justifies larger scale clinical trial to establish a potential link between oscillatory markers, therapeutic management and disease prognosis
ACCEPTED MANUSCRIPT
53. 54.
55.
56.
57.
58. 59.
60.
61. 62.
63.
64.
RI PT
SC
52.
M AN U
51.
TE D
50.
EP
49.
Lavie P, Lavie L. Unexpected survival advantage in elderly people with moderate sleep apnoea. J Sleep Res. 2009;18(4):397-403. Lavie P, Lavie L, Herer P. All-cause mortality in males with sleep apnoea syndrome: declining mortality rates with age. Eur Respir J. 2005;25(3):514-520. Magalhaes J, Falcao-Pires I, Goncalves IO, et al. Synergistic impact of endurance training and intermittent hypobaric hypoxia on cardiac function and mitochondrial energetic and signaling. Int J Cardiol. 2013;168(6):5363-5371. Ma HJ, Li Q, Guan Y, et al. Chronic intermittent hypobaric hypoxia ameliorates ischemia/reperfusion-induced calcium overload in heart via Na/Ca2+ exchanger in developing rats. Cell Physiol Biochem. 2014;34(2):313-324. Molkov YI, Zoccal DB, Baekey DM, et al. Physiological and pathophysiological interactions between the respiratory central pattern generator and the sympathetic nervous system. Prog Brain Res. 2014;212:1-23. Willie CK, Ainslie PN, Drvis I, et al. Regulation of brain blood flow and oxygen delivery in elite breath-hold divers. J Cereb Blood Flow Metab. 2015;35(1):66-73. Tominaga S, Strandgaard S, Uemura K, Ito K, Kutsuzawa T. Cerebrovascular CO2 reactivity in normotensive and hypertensive man. Stroke. 1976;7(5):507510. Aaslid R, Markwalder TM, Nornes H. Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. J Neurosurg. 1982;57(6):769774. Ogoh S, Sato K, Fisher JP, Seifert T, Overgaard M, Secher NH. The effect of phenylephrine on arterial and venous cerebral blood flow in healthy subjects. Clin Physiol Funct Imaging. 2011;31(6):445-451. Wilson MH, Edsell ME, Davagnanam I, et al. Cerebral artery dilatation maintains cerebral oxygenation at extreme altitude and in acute hypoxia--an ultrasound and MRI study. J Cereb Blood Flow Metab. 2011;31(10):2019-2029. Willie CK, Macleod DB, Shaw AD, et al. Regional brain blood flow in man during acute changes in arterial blood gases. J Physiol. 2012;590(14):3261-3275. Szarmach A, Winklewski PJ, Halena G, et al. Morphometric evaluation of the delayed cerebral arteries response to acetazolamide test in patients with chronic carotid artery stenosis using computed tomography angiography. Folia Morphol (Warsz). 2017;76(1):10-14. Placidi F, Diomedi M, Cupini LM, Bernardi G, Silvestrini M. Impairment of daytime cerebrovascular reactivity in patients with obstructive sleep apnoea syndrome. J Sleep Res. 1998;7(4):288-292. Urbano F, Roux F, Schindler J, Mohsenin V. Impaired cerebral autoregulation in obstructive sleep apnea. J Appl Physiol (1985). 2008;105(6):1852-1857. Morgan BJ, Reichmuth KJ, Peppard PE, et al. Effects of sleep-disordered breathing on cerebrovascular regulation: A population-based study. Am J Respir Crit Care Med. 2010;182(11):1445-1452. Diomedi M, Placidi F, Cupini LM, Bernardi G, Silvestrini M. Cerebral hemodynamic changes in sleep apnea syndrome and effect of continuous positive airway pressure treatment. Neurology. 1998;51(4):1051-1056. Roberts TP, Mikulis D. Neuro MR: principles. J Magn Reson Imaging. 2007;26(4):823-837.
AC C
48.
ACCEPTED MANUSCRIPT
70.
71.
72. 73.
74. 75.
76.
77.
78. 79.
80.
RI PT
SC
69.
M AN U
68.
TE D
67.
EP
66.
Bhogal AA, Siero JC, Fisher JA, et al. Investigating the non-linearity of the BOLD cerebrovascular reactivity response to targeted hypo/hypercapnia at 7T. Neuroimage. 2014;98:296-305. Bhogal AA, Philippens ME, Siero JC, et al. Examining the regional and cerebral depth-dependent BOLD cerebrovascular reactivity response at 7T. Neuroimage. 2015;114:239-248. Prilipko O, Huynh N, Thomason ME, Kushida CA, Guilleminault C. An fMRI study of cerebrovascular reactivity and perfusion in obstructive sleep apnea patients before and after CPAP treatment. Sleep Med. 2014;15(8):892-898. Peterson EC, Wang Z, Britz G. Regulation of cerebral blood flow. Int J Vasc Med. 2011;2011:823525. Gillard JH, Minhas PS, Hayball MP, et al. Assessment of quantitative computed tomographic cerebral perfusion imaging with H2(15)O positron emission tomography. Neurol Res. 2000;22(5):457-464. Sakai F, Nakazawa K, Tazaki Y, et al. Regional cerebral blood volume and hematocrit measured in normal human volunteers by single-photon emission computed tomography. J Cereb Blood Flow Metab. 1985;5(2):207-213. Firlik AD, Kaufmann AM, Wechsler LR, Firlik KS, Fukui MB, Yonas H. Quantitative cerebral blood flow determinations in acute ischemic stroke. Relationship to computed tomography and angiography. Stroke. 1997;28(11):2208-2213. Detre JA, Leigh JS, Williams DS, Koretsky AP. Perfusion imaging. Magn Reson Med. 1992;23(1):37-45. Robson PM, Dai W, Shankaranarayanan A, Rofsky NM, Alsop DC. Time-resolved vessel-selective digital subtraction MR angiography of the cerebral vasculature with arterial spin labeling. Radiology. 2010;257(2):507-515. MacDonald ME, Frayne R. Cerebrovascular MRI: a review of state-of-the-art approaches, methods and techniques. NMR Biomed. 2015;28(7):767-791. Yaouhi K, Bertran F, Clochon P, et al. A combined neuropsychological and brain imaging study of obstructive sleep apnea. Journal of Sleep Research. 2009;18(1):36-48. Innes CR, Kelly PT, Hlavac M, Melzer TR, Jones RD. Decreased Regional Cerebral Perfusion in Moderate-Severe Obstructive Sleep Apnoea during Wakefulness. Sleep. 2015;38(5):699-706. Meyer JS, Sakai F, Karacan I, Derman S, Yamamoto M. Sleep apnea, narcolepsy, and dreaming: regional cerebral hemodynamics. Ann Neurol. 1980;7(5):479-485. Meyer JS, Ishikawa Y, Hata T, Karacan I. Cerebral blood flow in normal and abnormal sleep and dreaming. Brain Cogn. 1987;6(3):266-294. Joo EY, Tae WS, Han SJ, Cho JW, Hong SB. Reduced cerebral blood flow during wakefulness in obstructive sleep apnea-hypopnea syndrome. Sleep. 2007;30(11):1515-1520. Baril AA, Gagnon K, Arbour C, et al. Regional Cerebral Blood Flow during Wakeful Rest in Older Subjects with Mild to Severe Obstructive Sleep Apnea. Sleep. 2015;38(9):1439-1449.
AC C
65.
ACCEPTED MANUSCRIPT
85. 86.
87. 88.
89.
90.
91.
92.
93.
SC
M AN U
84.
TE D
83.
EP
82.
Baron JC, Lebrun-Grandie P, Collard P, Crouzel C, Mestelan G, Bousser MG. Noninvasive measurement of blood flow, oxygen consumption, and glucose utilization in the same brain regions in man by positron emission tomography: concise communication. J Nucl Med. 1982;23(5):391-399. Buckner RL, Andrews-Hanna JR, Schacter DL. The brain's default network: anatomy, function, and relevance to disease. Ann N Y Acad Sci. 2008;1124:1-38. Antczak J, Popp R, Hajak G, Zulley J, Marienhagen J, Geisler P. Positron emission tomography findings in obstructive sleep apnea patients with residual sleepiness treated with continuous positive airway pressure. J Physiol Pharmacol. 2007;58 Suppl 5(Pt 1):25-35. Dampney RA. Brain stem mechanisms in the control of arterial pressure. Clin Exp Hypertens. 1981;3(3):379-391. Kasparov S, Teschemacher AG. Altered central catecholaminergic transmission and cardiovascular disease. Exp Physiol. 2008;93(6):725-740. Macefield VG, Henderson LA. "Real-time" imaging of cortical and subcortical sites of cardiovascular control: concurrent recordings of sympathetic nerve activity and fMRI in awake subjects. J Neurophysiol. 2016;116(3):1199-1207. Somers VK, Dyken ME, Mark AL, Abboud FM. Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med. 1993;328(5):303-307. Dampney RA, Horiuchi J, Tagawa T, Fontes MA, Potts PD, Polson JW. Medullary and supramedullary mechanisms regulating sympathetic vasomotor tone. Acta Physiol Scand. 2003;177(3):209-218. Dampney RA, Polson JW, Potts PD, Hirooka Y, Horiuchi J. Functional organization of brain pathways subserving the baroreceptor reflex: studies in conscious animals using immediate early gene expression. Cell Mol Neurobiol. 2003;23(4-5):597-616. Macefield VG, Henderson LA. Real-time imaging of the medullary circuitry involved in the generation of spontaneous muscle sympathetic nerve activity in awake subjects. Hum Brain Mapp. 2010;31(4):539-549. James C, Macefield VG, Henderson LA. Real-time imaging of cortical and subcortical control of muscle sympathetic nerve activity in awake human subjects. Neuroimage. 2013;70:59-65. Carlson JT, Hedner JA, Sellgren J, Elam M, Wallin BG. Depressed baroreflex sensitivity in patients with obstructive sleep apnea. Am J Respir Crit Care Med. 1996;154(5):1490-1496. Greenberg HE, Sica AL, Scharf SM, Ruggiero DA. Expression of c-fos in the rat brainstem after chronic intermittent hypoxia. Brain Res. 1999;816(2):638-645.
AC C
81.
RI PT
** Older individuals with severe OSA are characterized by hypoperfusion in the sensorimotor and parietal areas. Respiratory variables and subjective sleepiness are correlated with extended regions of hypoperfusion in the lateral cortex. OSA severity, sleep fragmentation, and obesity correlates with increased perfusion in subcortical and medial cortical regions. Anomalies with such a distribution could result in cognitive deficits and reflect impaired vascular regulation, altered neuronal integrity, and/or undergoing neurodegenerative processes
ACCEPTED MANUSCRIPT
95. 96.
97.
M AN U
SC
98.
Sica AL, Greenberg HE, Scharf SM, Ruggiero DA. Chronic-intermittent hypoxia induces immediate early gene expression in the midline thalamus and epithalamus. Brain Res. 2000;883(2):224-228. Logothetis NK, Pauls J, Augath M, Trinath T, Oeltermann A. Neurophysiological investigation of the basis of the fMRI signal. Nature. 2001;412(6843):150-157. Lundblad LC, Fatouleh RH, Hammam E, McKenzie DK, Macefield VG, Henderson LA. Brainstem changes associated with increased muscle sympathetic drive in obstructive sleep apnoea. Neuroimage. 2014;103:258-266. Henderson LA, Fatouleh RH, Lundblad LC, McKenzie DK, Macefield VG. Effects of 12 Months Continuous Positive Airway Pressure on Sympathetic Activity Related Brainstem Function and Structure in Obstructive Sleep Apnea. Front Neurosci. 2016;10:90. Lundblad LC, Fatouleh RH, McKenzie DK, Macefield VG, Henderson LA. Brain stem activity changes associated with restored sympathetic drive following CPAP treatment in OSA subjects: a longitudinal investigation. J Neurophysiol. 2015;114(2):893-901.
RI PT
94.
** CPAP treatment completely reverses brain stem functional changes associated with elevated peripheral muscle sympathetic nerve activity in untreated OSA subjects
99.
TE D
100.
Fatouleh RH, Hammam E, Lundblad LC, et al. Functional and structural changes in the brain associated with the increase in muscle sympathetic nerve activity in obstructive sleep apnoea. Neuroimage Clin. 2014;6:275-283. Fatouleh RH, Lundblad LC, Macey PM, McKenzie DK, Henderson LA, Macefield VG. Reversal of functional changes in the brain associated with obstructive sleep apnoea following 6 months of CPAP. Neuroimage Clin. 2015;7:799-806.
101.
102.
103.
AC C
EP
** Following 6 months of CPAP treatment the reduction in resting peripheral muscle sympathetic nerve activity is coupled with significant falls in signal intensity in the precuneus bilaterally, left and right insula, right medial prefrontal cortex, right anterior cingulate cortex, right parahippocampus and left and right retrosplenial cortices. These data support the concept that functional changes in these suprabulbar sites are driving the augmented sympathetic outflow (via projections to the brainstem) to the muscle vascular bed in untreated OSA.
Ciftci TU, Kokturk O, Bukan N, Bilgihan A. The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine. 2004;28(2):87-91. Svensson M, Venge P, Janson C, Lindberg E. Relationship between sleepdisordered breathing and markers of systemic inflammation in women from the general population. J Sleep Res. 2012;21(2):147-154. Calhoun DA, Nishizaka MK, Zaman MA, Harding SM. Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea. Chest. 2004;125(1):112-117.
ACCEPTED MANUSCRIPT
106. 107.
108.
RI PT
105.
Sim JJ, Yan EH, Liu IL, et al. Positive relationship of sleep apnea to hyperaldosteronism in an ethnically diverse population. J Hypertens. 2011;29(8):1553-1559. Felder RB, Yu Y, Zhang ZH, Wei SG. Pharmacological treatment for heart failure: a view from the brain. Clin Pharmacol Ther. 2009;86(2):216-220. Felder RB. Mineralocorticoid receptors, inflammation and sympathetic drive in a rat model of systolic heart failure. Exp Physiol. 2010;95(1):19-25. Shi Z, Gan XB, Fan ZD, et al. Inflammatory cytokines in paraventricular nucleus modulate sympathetic activity and cardiac sympathetic afferent reflex in rats. Acta Physiol (Oxf). 2011;203(2):289-297. Paton JF, Waki H. Is neurogenic hypertension related to vascular inflammation of the brainstem? Neurosci Biobehav Rev. 2009;33(2):89-94.
SC
104.
* Based on the animal models the concept of brain vascular inflammatory processes in the development of hypertension is discussed.
113.
114.
115.
116.
117.
118.
M AN U
112.
TE D
111.
EP
110.
Saavedra JM. Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders. Clin Sci (Lond). 2012;123(10):567-590. Wu KL, Chan SH, Chan JY. Neuroinflammation and oxidative stress in rostral ventrolateral medulla contribute to neurogenic hypertension induced by systemic inflammation. J Neuroinflammation. 2012;9:212. de Kloet AD, Krause EG, Shi PD, Zubcevic J, Raizada MK, Sumners C. Neuroimmune communication in hypertension and obesity: a new therapeutic angle? Pharmacol Ther. 2013;138(3):428-440. Paton JF, Wang S, Polson JW, Kasparov S. Signalling across the blood brain barrier by angiotensin II: novel implications for neurogenic hypertension. J Mol Med (Berl). 2008;86(6):705-710. Guillot FL, Audus KL. Angiotensin peptide regulation of bovine brain microvessel endothelial cell monolayer permeability. J Cardiovasc Pharmacol. 1991;18(2):212-218. Fleegal-DeMotta MA, Doghu S, Banks WA. Angiotensin II modulates BBB permeability via activation of the AT(1) receptor in brain endothelial cells. J Cereb Blood Flow Metab. 2009;29(3):640-647. Zhang M, Mao Y, Ramirez SH, Tuma RF, Chabrashvili T. Angiotensin II induced cerebral microvascular inflammation and increased blood-brain barrier permeability via oxidative stress. Neuroscience. 2010;171(3):852-858. Biancardi VC, Son SJ, Ahmadi S, Filosa JA, Stern JE. Circulating angiotensin II gains access to the hypothalamus and brain stem during hypertension via breakdown of the blood-brain barrier. Hypertension. 2014;63(3):572-579. Labus J, Hackel S, Lucka L, Danker K. Interleukin-1beta induces an inflammatory response and the breakdown of the endothelial cell layer in an improved human THBMEC-based in vitro blood-brain barrier model. J Neurosci Methods. 2014;228:35-45. Rochfort KD, Collins LE, Murphy RP, Cummins PM. Downregulation of bloodbrain barrier phenotype by proinflammatory cytokines involves NADPH oxidasedependent ROS generation: consequences for interendothelial adherens and tight junctions. PLoS One. 2014;9(7):e101815.
AC C
109.
ACCEPTED MANUSCRIPT
124.
125.
126.
127. 128. 129.
130.
131. 132.
133. 134. 135.
136.
RI PT
SC
123.
M AN U
122.
TE D
121.
EP
120.
Xu W, Chi L, Row BW, et al. Increased oxidative stress is associated with chronic intermittent hypoxia-mediated brain cortical neuronal cell apoptosis in a mouse model of sleep apnea. Neuroscience. 2004;126(2):313-323. Kiernan EA, Smith SM, Mitchell GS, Watters JJ. Mechanisms of microglial activation in models of inflammation and hypoxia: Implications for chronic intermittent hypoxia. J Physiol. 2016;594(6):1563-1577. Winklewski PJ, Radkowski M, Demkow U. Neuroinflammatory mechanisms of hypertension: potential therapeutic implications. Curr Opin Nephrol Hypertens. 2016;25(5):410-416. Smith SM, Friedle SA, Watters JJ. Chronic intermittent hypoxia exerts CNS region-specific effects on rat microglial inflammatory and TLR4 gene expression. PLoS One. 2013;8(12):e81584. Chen HL, Lu CH, Lin HC, et al. White matter damage and systemic inflammation in obstructive sleep apnea. Sleep. 2015;38(3):361-370. He Y, Chen R, Wang J, et al. Neurocognitive impairment is correlated with oxidative stress in patients with moderate-to-severe obstructive sleep apnea hypopnea syndrome. Respir Med. 2016;120:25-30. Sarma MK, Macey PM, Nagarajan R, Aysola R, Harper RM, Thomas MA. Accelerated Echo Planer J-resolved Spectroscopic Imaging of Putamen and Thalamus in Obstructive Sleep Apnea. Sci Rep. 2016;6:31747. Alkan A, Sharifov R, Akkoyunlu ME, et al. MR spectroscopy features of brain in patients with mild and severe obstructive sleep apnea syndrome. Clin Imaging. 2013;37(6):989-992. Yadav SK, Kumar R, Macey PM, Woo MA, Yan-Go FL, Harper RM. Insular cortex metabolite changes in obstructive sleep apnea. Sleep. 2014;37(5):951-958. Lassen NA. Cerebral blood flow and oxygen consumption in man. Physiol Rev. 1959;39(2):183-238. Lucas SJ, Tzeng YC, Galvin SD, Thomas KN, Ogoh S, Ainslie PN. Influence of changes in blood pressure on cerebral perfusion and oxygenation. Hypertension. 2010;55(3):698-705. Tzeng YC, MacRae BA, Ainslie PN, Chan GS. Fundamental relationships between blood pressure and cerebral blood flow in humans. J Appl Physiol (1985). 2014;117(9):1037-1048. Hurford WE, Hong SK, Park YS, et al. Splenic contraction during breath-hold diving in the Korean ama. J Appl Physiol (1985). 1990;69(3):932-936. Schagatay E, Andersson JP, Hallen M, Palsson B. Selected contribution: role of spleen emptying in prolonging apneas in humans. J Appl Physiol (1985). 2001;90(4):1623-1629; discussion 1606. Frances MF, Dujic Z, Shoemaker JK. Splenic constriction during isometric handgrip exercise in humans. Appl Physiol Nutr Metab. 2008;33(5):990-996. Bakovic D, Valic Z, Eterovic D, et al. Spleen volume and blood flow response to repeated breath-hold apneas. J Appl Physiol (1985). 2003;95(4):1460-1466. Vigetun-Haughey H, Appelberg J, Forsberg T, Kaldensjo M, Schagatay E. Voluntary apnea evokes diving responses in obstructive sleep apnea patients. Eur J Appl Physiol. 2015;115(5):1029-1036. Safar ME, Struijker-Boudier HA. Cross-talk between macro- and microcirculation. Acta Physiol (Oxf). 2010;198(4):417-430.
AC C
119.
ACCEPTED MANUSCRIPT
142. 143.
144.
145.
146.
147.
148. 149.
150.
151.
RI PT
SC
141.
M AN U
140.
TE D
139.
EP
138.
Svedmyr S, Zou D, Sommermeyer D, et al. Vascular stiffness determined from a nocturnal digital pulse wave signal: association with sleep, sleep-disordered breathing, and hypertension. J Hypertens. 2016;34(12):2427-2433. Chami HA, Vasan RS, Larson MG, Benjamin EJ, Mitchell GF, Gottlieb DJ. The association between sleep-disordered breathing and aortic stiffness in a community cohort. Sleep Med. 2016;19:69-74. Macey PM, Kumar R, Ogren JA, Woo MA, Harper RM. Global brain blood-oxygen level responses to autonomic challenges in obstructive sleep apnea. PLoS One. 2014;9(8):e105261. Georgiadis D, Sievert M, Cencetti S, et al. Cerebrovascular reactivity is impaired in patients with cardiac failure. Eur Heart J. 2000;21(5):407-413. Ogoh S, Tzeng YC, Lucas SJ, Galvin SD, Ainslie PN. Influence of baroreflexmediated tachycardia on the regulation of dynamic cerebral perfusion during acute hypotension in humans. J Physiol. 2010;588(Pt 2):365-371. Macey PM, Kumar R, Woo MA, Yan-Go FL, Harper RM. Heart rate responses to autonomic challenges in obstructive sleep apnea. PLoS One. 2013;8(10):e76631. Wszedybyl-Winklewska M, Wolf J, Swierblewska E, et al. Increased inspiratory resistance affects the dynamic relationship between blood pressure changes and subarachnoid space width oscillations. PLOS ONE. 2017;Ehead of print. Winklewski PJ, Gruszecki M, Wolf J, et al. Wavelet transform analysis to assess oscillations in pial artery pulsation at the human cardiac frequency. Microvasc Res. 2015;99:86-91. Winklewski PJ, Barak O, Madden D, et al. Effect of Maximal Apnoea Easy-Going and Struggle Phases on Subarachnoid Width and Pial Artery Pulsation in Elite Breath-Hold Divers. PLoS One. 2015;10(8):e0135429. Winklewski PJ, Tkachenko Y, Mazur K, et al. Sympathetic Activation Does Not Affect the Cardiac and Respiratory Contribution to the Relationship between Blood Pressure and Pial Artery Pulsation Oscillations in Healthy Subjects. PLoS One. 2015;10(8):e0135751. Bateman GA, Levi CR, Schofield P, Wang Y, Lovett EC. The venous manifestations of pulse wave encephalopathy: windkessel dysfunction in normal aging and senile dementia. Neuroradiology. 2008;50(6):491-497. Baumbach GL. Effects of increased pulse pressure on cerebral arterioles. Hypertension. 1996;27(2):159-167. Hirata K, Yaginuma T, O'Rourke MF, Kawakami M. Age-related changes in carotid artery flow and pressure pulses: possible implications for cerebral microvascular disease. Stroke. 2006;37(10):2552-2556. Henskens LH, Kroon AA, van Oostenbrugge RJ, et al. Increased aortic pulse wave velocity is associated with silent cerebral small-vessel disease in hypertensive patients. Hypertension. 2008;52(6):1120-1126. Jolly TA, Bateman GA, Levi CR, Parsons MW, Michie PT, Karayanidis F. Early detection of microstructural white matter changes associated with arterial pulsatility. Front Hum Neurosci. 2013;7:782.
AC C
137.
** Increased arterial pulsatility may increase perivascular shear stress and lead to accumulated damage to perivascular oligodendrocytes, resulting in microstructural changes in white matter and contributing to proliferation of leukoaraiosis over time. The
ACCEPTED MANUSCRIPT
study by Jolly et al. establishes a potential causal link between pulse wave encephalopathy and white matter abnormalities in OSA
155.
156. 157.
RI PT
154.
SC
153.
Magnano C, Schirda C, Weinstock-Guttman B, et al. Cine cerebrospinal fluid imaging in multiple sclerosis. J Magn Reson Imaging. 2012;36(4):825-834. Beggs CB, Magnano C, Shepherd SJ, et al. Dirty-Appearing White Matter in the Brain is Associated with Altered Cerebrospinal Fluid Pulsatility and Hypertension in Individuals without Neurologic Disease. J Neuroimaging. 2016;26(1):136-143. Frydrychowski AF, Guminski W, Rojewski M, Kaczmarek J, Juzwa W. Technical foundations for noninvasive assessment of changes in the width of the subarachnoid space with near-infrared transillumination-backscattering sounding (NIR-TBSS). IEEE Trans Biomed Eng. 2002;49(8):887-904. Plucinski J, Frydrychowski AF. New aspects in assessment of changes in width of subarachnoid space with near-infrared transillumination/backscattering sounding, part 1: Monte Carlo numerical modeling. J Biomed Opt. 2007;12(4):044015. Frydrychowski AF, Szarmach A, Czaplewski B, Winklewski PJ. Subarachnoid space: new tricks by an old dog. PLoS One. 2012;7(5):e37529. Jennum P, Borgesen SE. Intracranial pressure and obstructive sleep apnea. Chest. 1989;95(2):279-283.
M AN U
152.
** Study demonstrated that intracranial pressure increases during apnoeic episodes in OSA subjects, and the differences in intracranial pressure correlated with systemic blood pressure fluctuations
161. 162.
163.
TE D
160.
EP
159.
Sugita Y, Iijima S, Teshima Y, et al. Marked episodic elevation of cerebrospinal fluid pressure during nocturnal sleep in patients with sleep apnea hypersomnia syndrome. Electroencephalogr Clin Neurophysiol. 1985;60(3):214-219. Purvin VA, Kawasaki A, Yee RD. Papilledema and obstructive sleep apnea syndrome. Arch Ophthalmol. 2000;118(12):1626-1630. Wall M, Purvin V. Idiopathic intracranial hypertension in men and the relationship to sleep apnea. Neurology. 2009;72(4):300-301. Fraser CL. Obstructive sleep apnea and optic neuropathy: is there a link? Curr Neurol Neurosci Rep. 2014;14(8):465. Thurtell MJ, Trotti LM, Bixler EO, et al. Obstructive sleep apnea in idiopathic intracranial hypertension: comparison with matched population data. J Neurol. 2013;260(7):1748-1751. Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177(9):1006-1014.
AC C
158.
* up-to-date prevalence of sleep apnea in adult population
164.
Cushing H. Concerning a definite regulatory mechanism of the vasomotor centre which controls blood pressure during cerebral compression. Bull Johns Hopk Hosp. 1901;12:290-292.
ACCEPTED MANUSCRIPT
RI PT
SC M AN U
168.
TE D
167.
EP
166.
Dickinson CJ, Mc Cubbin J. Pressor effect of increased cerebrospinal fluid pressure and vertebral artery occlusion with and without anesthesia. Circ Res. 1963;12:190-202. Schmidt EA, Czosnyka Z, Momjian S, Czosnyka M, Bech RA, Pickard JD. Intracranial baroreflex yielding an early cushing response in human. Acta Neurochir Suppl. 2005;95:253-256. McBryde FD, Malpas SC, Paton JF. Intracranial mechanisms for preserving brain blood flow in health and disease. Acta Physiol (Oxf). 2017;219(1):274-287. Wolf J, Narkiewicz K. Optimizing the management of uncontrolled/resistant hypertension. The importance of sleep apnoea syndrome. Curr Vasc Pharmacol. 2017.
AC C
165.
Baroreceptors
BP
M AN U
( )
SC
(+)
(+)
(+)* (+)
NTS
(+)
( ) CVLM
( )
SNS outflow
AC C
EP
TE D
OSA (+)
RI PT
ACCEPTED MANUSCRIPT
(+) RVLM
ACCEPTED MANUSCRIPT
Blood
RI PT
CSF
(+)
PVN
Angiotensin II
SC
(+)
M AN U
Blood-brain barrier
(+)
IL-1β IL-6
disintegration
RVLM
TE D
processes
(+)
(+)
AC C
EP
(+)
TNF-α
SNS outflow
Untreated OSA
(+)
ACCEPTED MANUSCRIPT
Pulse wave encephalopathy Brain inflammation
Idiopathic intracranial hypertension
M AN U
SC
RAAS activation
RI PT
Systemic inflammation
SNS activation
AC C
EP
TE D
Hypertension
Increased blood flow puslatility
(-)
Cerebral oxygenation instability
Normal breathing restoration in OSA (e.g. nCPAP-use)
Cerebral perfusion instability